BRS and Outcomes in Cardiothoracic Surgery

July 20, 2022 updated by: Duke University

Role of Preoperative Baroreflex Sensitivity on Major Outcomes After Cardiothoracic Surgery

The purpose of this study is to determine whether baroreceptor sensitivity (the ability of your body to change your heart rate and/or blood pressure in response to a situation) has any effect on how likely you are to suffer certain events after heart or lung surgery. The postoperative events that the investigators will be studying are pain after surgery, atrial fibrillation (an irregular heart rhythm), and cognitive dysfunction (a decline in mental abilities).

Study Overview

Detailed Description

The purpose of this study is to determine if preoperative baroreceptor sensitivity (BRS) correlates with major outcomes after cardiac and thoracic surgery, including acute and chronic pain, atrial arrhythmias, and cognitive function. To test this hypothesis, approximately 95 patients will be enrolled, and spontaneous baroreceptor sensitivity will be measured prior to surgery as well as immediately postoperatively. Outcomes will include acute pain using the numeric rating scale, Brief Pain Inventory, and Gracely Box Scale administered preoperatively, on postoperative days 1 and 2 and by phone at 6-weeks postoperatively. Chronic pain will be assessed at 6-month follow-up visit via hyperalgesia testing using Von Frey filaments. Postoperative atrial arrhythmias will be assessed by review of postoperative telemetry, the electronic medical record, and ECG performed prior to discharge. Finally, cognitive function will be assess via Mini-Mental State examination administered preoperative and at the 6-month follow-up visit. Association between BRS and the outcomes of interest will be tested with regression models adjusted for appropriate covariates. Significance threshold alpha will be adjusted for the number of statistical tests using the Bonferroni correction. Our hypothesis is that patients with impaired preoperative BRS will have an increased incidence of acute and chronic postoperative pain, atrial fibrillation, and cognitive decline after surgery.

Study Type

Observational

Enrollment (Actual)

72

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients presenting for cardiac and thoracic surgery at Duke University Hospital, a quaternary referral center

Description

Inclusion Criteria:

  • >= 18 years of age
  • Undergoing cardiac (coronary artery bypass grafting [CABG], CABG + valve, or valve only) or thoracic (video-assisted thoracoscopic [VATS] approach to lobectomy) surgery

Exclusion Criteria:

  • Any preexisting pain condition (defined as pain of >=3 months duration prior to enrollment)
  • Pain at the time of enrollment interview
  • Need for preoperative analgesics
  • Preexisting chronic or paroxysmal atrial fibrillation
  • Preexisting atrial or ventricular arrhythmia
  • Need for preoperative anti-arrhythmic medication
  • History of symptomatic cerebrovascular disease (e.g., prior stroke) with residual deficits
  • Alcoholism (>2 drinks/day)
  • Psychiatric illness (any clinical diagnosis requiring therapy)
  • Drug abuse (any illicit drug use in the preceding 3 months before surgery)
  • Hepatic insufficiency (liver function tests > 1.5 times the upper limit of normal)
  • Severe pulmonary insufficiency (home oxygen)
  • Renal failure (serum creatinine >2.0 mg/dL)
  • Non-English speaking
  • Unable to read
  • Participants who score <24 on baseline Mini Mental State examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Surgical
No interventions. Patients undergoing cardiothoracic surgery will be assessed for baroreflex sensitivity and the outcomes of interest.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline baroreflex sensitivity
Time Frame: 30 min
Non-invasive BRS testing with BIOPAC MP160
30 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative day (POD) 1 baroreflex sensitivity
Time Frame: 30 min
Non-invasive BRS testing with BIOPAC MP160
30 min
POD 2 baroreflex sensitivity
Time Frame: 30 min
Non-invasive BRS testing with BIOPAC MP160
30 min
6 month baroreflex sensitivity
Time Frame: 6 months
Non-invasive BRS testing with BIOPAC MP160
6 months
Acute postoperative pain as assessed by the numeric rating scale (NRS) - 24h
Time Frame: 24 hours
Median NRS pain score in the first 24h after surgery
24 hours
Acute postoperative pain as assessed by the numeric rating scale (NRS) - 48h
Time Frame: 48 hours
Median NRS pain score in the second 24h after surgery
48 hours
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - POD1
Time Frame: 15 min
GBS survey on POD 1
15 min
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - POD2
Time Frame: 15 min
GBS survey on POD 2
15 min
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - 6 mo
Time Frame: 6 months
GBS survey at 6 month follow-up visit
6 months
Chronic pain as assessed by the change in Brief Pain Inventory score
Time Frame: Baseline, 6 months
Change from baseline to 6 months postoperatively
Baseline, 6 months
Hyperalgesia
Time Frame: 6 months
Nociceptive threshold as assessed by Von Frey filament testing at 6 month follow-up
6 months
Area of hyperalgesia or allodynia
Time Frame: 6 months
Area surrounding operative incision as assessed by Von Frey filament testing at 6 month follow-up
6 months
Postoperative atrial fibrillation
Time Frame: 6 weeks
Chart review assessment of the occurrence of postoperative atrial fibrillation during hospitalization and up to 6 weeks postoperatively
6 weeks
Postoperative cognitive change
Time Frame: Baseline, 6 months
Change from baseline to 6 months in the Mini Mental Status Exam score
Baseline, 6 months
Baseline psychological distress
Time Frame: 15 min
As assessed by the Brief Symptom Inventory-18
15 min
6 month psychological distress
Time Frame: 6 months
As assessed by the Brief Symptom Inventory-18
6 months
Baseline frailty
Time Frame: 10 min
As assessed by the Modified Frailty Index
10 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2017

Primary Completion (Actual)

December 15, 2021

Study Completion (Actual)

May 31, 2022

Study Registration Dates

First Submitted

August 2, 2017

First Submitted That Met QC Criteria

August 3, 2017

First Posted (Actual)

August 8, 2017

Study Record Updates

Last Update Posted (Actual)

July 21, 2022

Last Update Submitted That Met QC Criteria

July 20, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

3
Subscribe